AntTail tracks temperature changes from pallets to patients’ homes 20-Feb-2020 By Ben Hargreaves AntTail builds an end-to-end application that is able to track temperature of medicine and detect evidence of tampering.
FDA and Indian agencies discover 500 illegal shipments entering the US 20-Feb-2020 By Vassia Barba The drugs including unapproved cancer, HIV, and opioid treatments, which were identified during a three-day operation at a mail facility.
Formulation technology improving CBD uptake bought out 20-Feb-2020 By Vassia Barba Bioavailability of water insoluble compounds, such as CBD, enhanced up to 15 times with the technology of Solmic, leading to its acquisition by Betterlife.
‘You get what you pay for’ on API quality 19-Feb-2020 By Ben Hargreaves As C2 Pharma works to expand its API portfolio, its CEO states that there is ‘no short game’ on API quality.
Lupin denies quality is a company-wide issue despite run ins with FDA 18-Feb-2020 By Nick Taylor Lupin refutes suggestion that history of manufacturing quality failings highlighted by the US FDA reflect a company-wide issue.
Tetra in manufacturing deal for printed CBD treatment 18-Feb-2020 By Ben Hargreaves Tetra Bio-Pharma signs agreement for the commercial manufacture of two CBD-based drug candidates.
ACG blockchain service to bridge ‘digitally broken’ supply chains 18-Feb-2020 By Vassia Barba ACG Inspection rides the technology wave with the launch of a blockchain-based software platform, aiming to meet industry demands on traceability.
Dr Reddy’s picks up portfolio and facility from rival for $259m 17-Feb-2020 By Ben Hargreaves Wockhardt sells part of its domestic business to fund growth in international markets and to develop its biosimilar business.
Testing service looks to ensure glass packaging adequacy 17-Feb-2020 By Vassia Barba Glass packaging provider joins forces with a vacuum pump manufacturer to design a packaging testing service.
Sun Pharma blames 'speculative buying' on coronavirus-related price hikes 17-Feb-2020 By Nick Taylor Sun Pharma argues rising ingredient and finished product prices are unjustified, blames ‘speculative buying’ for trend.
Industry demands ‘closest possible relationship’ between UK and EU 13-Feb-2020 By Ben Hargreaves European industry organizations call for trade negotiations between the UK and the EU to begin with a mutual recognition agreement.
AZ invests in trees and production in Australia 13-Feb-2020 By Ben Hargreaves The company revealed that it plans to plant 25 million trees as part of its sustainability commitment.
Branded generics forecast to double revenues, with US and Europe left behind 12-Feb-2020 By Vassia Barba Global sales of branded generic drugs are expected to progress at 8% CAGR through 2029, but the US and Europe are not set to drive this growth.
Cardinal tips API supply chain to weather impact of coronavirus 10-Feb-2020 By Nick Taylor Cardinal predicts API industry ‘should be able to work through’ coronavirus outbreak despite exposure to China.
Biocon hit with FDA 483 after inspection of API facility 06-Feb-2020 By Nick Taylor US FDA issues Form 483 to Biocon facility after preapproval and GMP inspections.
